FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

RC Stadalnik

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Procedures

Concepts & Ideas

Kinetics

Living Beings

Rabbits

Co-author Network

Publications

TOP 3
RC Stadalnik; David R Vera
The evolution of (99m)Tc-NGA as a clinically useful receptor-binding radiopharmaceutical.
Moni Stein; David R Vera; RC Stadalnik
TIPS reduces hepatic asialoglycoprotein receptor concentration in healthy pigs.
Anne M Wallace; David R Vera; RC Stadalnik
Blue dye and 99mTc-labeled human serum albumin: sentinel node detection by magic bullets?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of RC Stadalnik (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: RC Stadalnik; David R Vera
The evolution of (99m)Tc-NGA as a clinically useful receptor-binding radiopharmaceutical.
Nuclear medicine and biology 2001;28(5):499-503.
2000: Moni Stein; David R Vera; RC Stadalnik
TIPS reduces hepatic asialoglycoprotein receptor concentration in healthy pigs.
Journal of vascular and interventional radiology : JVIR 2000;11(1):123-8.
1999: Anne M Wallace; David R Vera; RC Stadalnik
Blue dye and 99mTc-labeled human serum albumin: sentinel node detection by magic bullets?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(7):1149-50.
1999: Norihiro Kokudo; David R Vera; M Koizumi; Makoto Seki; T Sato; RC Stadalnik; Takashi Takahashi
Recovery of hepatic asialoglycoprotein receptors after major hepatic resection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(1):137-41.
1997: A Greenspan; RC Stadalnik
A musculoskeletal radiologist's view of nuclear medicine.
Seminars in nuclear medicine 1997;27(4):372-85.
1997: E J Gyetvai; RC Stadalnik
Scintigraphic 'eyebrow sign' on bone scan.
Clinical nuclear medicine 1997;22(6):419.
1997: David R Vera; Erik R Wisner; RC Stadalnik
Sentinel node imaging via a nonparticulate receptor-binding radiotracer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(4):530-5.
1996: J C Xu; David R Vera; RC Stadalnik
Automatic preparation of radiopharmacokinetic data for in vivo estimation of receptor biochemistry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(11):1896-902.
1996: A Greenspan; RC Stadalnik
Central versus eccentric lesions of long tubular bones.
Seminars in nuclear medicine 1996;26(3):201-6.
1996: C W Sutter; RC Stadalnik
Noncardiac uptake of technetium-99m sestamibi: an updated gamut.
Seminars in nuclear medicine 1996;26(2):135-40.
1996: David R Vera; RC Stadalnik; Charles E Metz; N R Pimstone
Diagnostic performance of a receptor-binding radiopharmacokinetic model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):160-4.
1995: C W Sutter; N H Beheshti; RC Stadalnik
Splenic infarction detected by Tc-99m RBC scintigraphy.
Clinical nuclear medicine 1995;20(10):927.
1995: A Greenspan; RC Stadalnik
Increased uptake around the hip joint.
Seminars in nuclear medicine 1995;25(3):283-6.
1995: C W Sutter; B G Masilungan; RC Stadalnik
False-positive results of I-131 whole-body scans in patients with thyroid cancer.
Seminars in nuclear medicine 1995;25(3):279-82.
1995: David R Vera; Michael H Buonocore; Erik R Wisner; Richard W Katzberg; RC Stadalnik
A molecular receptor-binding contrast agent for magnetic resonance imaging of the liver.
Academic radiology 1995;2(6):497-506.
1995: C W Sutter; RC Stadalnik
Unilateral absence or near absence of pulmonary perfusion on lung scanning.
Seminars in nuclear medicine 1995;25(1):72-4.
1994: N R Pimstone; RC Stadalnik; David R Vera; D P Hutak; W L Trudeau
Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog.
Hepatology (Baltimore, Md.) 1994;20(4 Pt 1):917-23.
1994: David R Vera; P O Scheibe; Y Banin; RC Stadalnik
Local identifiability of a receptor-binding radiopharmacokinetic system having measured parameters of known uncertainty.
IEEE transactions on bio-medical engineering 1994;41(9):891-7.
1994: B Brown; A Laorr; A Greenspan; RC Stadalnik
Negative bone scintigraphy with diffuse osteoblastic breast carcinoma metastases.
Clinical nuclear medicine 1994;19(3):194-6.
1994: C W Sutter; M J Joshi; RC Stadalnik
Noncardiac uptake of technetium-99m MIBI.
Seminars in nuclear medicine 1994;24(1):84-6.
1994: David R Vera; RC Stadalnik; M Kudo; K A Krohn
Radiopharmaceutical preparation of technetium-99m-labeled galactosyl neoglycoalbumin.
Methods in enzymology 1994;247():402-9.
1994: David R Vera; S J Topcu; RC Stadalnik
In vitro quantification of asialoglycoprotein receptor density from human hepatic microsamples.
Methods in enzymology 1994;247():394-402.
1994: Masatoshi Kudo; David R Vera; RC Stadalnik
In vivo quantification of asialoglycoprotein receptor.
Methods in enzymology 1994;247():373-82.
1993: Masatoshi Kudo; David R Vera; RC Stadalnik; C O Esquivel; W L Trudeau; Katsuji Ikekubo; Akio Todo
Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.
Digestive diseases and sciences 1993;38(12):2183-8.
1993: R A Cannon; RC Stadalnik
Postprandial gastric motility in infants with gastroesophageal reflux and delayed gastric emptying.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(12):2120-3.
1993: Masatoshi Kudo; Akio Todo; Katsuji Ikekubo; K Yamamoto; David R Vera; RC Stadalnik
Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin.
Hepatology (Baltimore, Md.) 1993;17(5):814-9.
1993: RC Stadalnik; M Kudo; William Eckelman; David R Vera
In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model.
Investigative radiology 1993;28(1):64-70.
1992: David R Vera; P O Scheibe; K A Krohn; W L Trudeau; RC Stadalnik
Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system.
IEEE transactions on bio-medical engineering 1992;39(4):356-67.
1991: M Kudo; David R Vera; W L Trudeau; RC Stadalnik
Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(6):1177-82.
1991: David R Vera; RC Stadalnik; W L Trudeau; P O Scheibe; K A Krohn
Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(6):1169-76.
1991: Masatoshi Kudo; David R Vera; RC Stadalnik; W L Trudeau; Katsuji Ikekubo; Akio Todo
[In vivo measurement of hepatic binding protein in chronic liver disease--validation as a measure of hepatic functional reserve].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 1991;88(1):40-50.
1991: M Kudo; David R Vera; W L Trudeau; RC Stadalnik
Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(7):663-6.
1990: Masatoshi Kudo; David R Vera; RC Stadalnik; W L Trudeau; Katsuji Ikekubo; Akio Todo
In vivo estimates of hepatic binding protein concentration: correlation with classical indicators of hepatic functional reserve.
The American journal of gastroenterology 1990;85(9):1142-8.
1989: David R Vera; E S Woodle; RC Stadalnik
Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(9):1519-30.
1989: E S Woodle; R E Ward; RC Stadalnik; David R Vera
Tc-NGA imaging in liver transplantation: preliminary clinical experience.
Surgery 1989;105(3):401-7.
1987: K L Cox; RC Stadalnik; John P McGahan; K Sanders; R A Cannon; B H Ruebner
Hepatobiliary scintigraphy with technetium-99m disofenin in the evaluation of neonatal cholestasis.
Journal of pediatric gastroenterology and nutrition 1987;6(6):885-91.
1987: K B Ford; B A Porter; RC Stadalnik; D W Brown
Functional causes of the ductal obstructive pattern on hepatobiliary scans.
Clinical nuclear medicine 1987;12(9):713-6.
1987: E S Woodle; David R Vera; RC Stadalnik; R E Ward
Tc-NGA imaging in liver transplantation: preclinical studies.
Surgery 1987;102(1):55-62.
1985: RC Stadalnik; David R Vera; E S Woodle; W L Trudeau; B A Porter; R E Ward; K A Krohn; L F O'Grady
Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(11):1233-42.
1985: David R Vera; RC Stadalnik; K A Krohn
Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(10):1157-67.
1985: David R Vera; K A Krohn; P O Scheibe; RC Stadalnik
Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system.
IEEE transactions on bio-medical engineering 1985;32(5):312-22.
1984: David R Vera; K A Krohn; RC Stadalnik; P O Scheibe
Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1984;25(7):779-87.
1984: David R Vera; K A Krohn; RC Stadalnik; P O Scheibe
Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.
Radiology 1984;151(1):191-6.
1983: N M Matolo; RC Stadalnik
Assessment of gastric motility using meal labeled with technetium-99m sulfur colloid.
American journal of surgery 1983;146(6):823-6.
1982: N M Matolo; RC Stadalnik; John P McGahan
Comparison of ultrasonography, computerized tomography, and radionuclide imaging in the diagnosis of acute and chronic cholecystitis.
American journal of surgery 1982;144(6):676-81.
1982: N M Matolo; RC Stadalnik
Biliary tract cholescintigraphy using technetium-99m-labeled disofenin.
The Journal of surgical research 1982;32(3):202-7.
1981: RC Stadalnik; C J Rosenquist; W L Trudeau; H H Hines
The value of radionuclide scintigraphy in patients with non-visualized gallbladders by oral cholecystography.
Clinical nuclear medicine 1981;6(11):519-22.
1981: RC Stadalnik; N M Matolo; A L Jansholt; David R Vera
Clinical experience with 99mTc-disofenin as a cholescintigraphic agent.
Radiology 1981;140(3):797-800.
1981: RC Stadalnik; N M Matolo
Radionuclide imaging of the biliary tree.
The Surgical clinics of North America 1981;61(4):827-42.
1980: N M Matolo; RC Stadalnik; S M Dixon
Value and limitations of scanning of the biliary tract.
Surgery, gynecology & obstetrics 1980;150(4):521-4.
1980: RC Stadalnik; J M Vogel; A L Jansholt; K A Krohn; N M Matolo; M C Lagunas-Solar; F W Zielinski
Renal clearance and extraction parameters of ortho-iodohippurate (I-123) compared with OIH(I-131) and PAH.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1980;21(2):168-70.